Logo.jpg
GT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
10 nov. 2022 15h15 HE | GT Biopharma, Inc.
Poster #1: Tri-specific killer engagers target natural killer cells towards mesotheliomaPoster #2: Enhancing NK cell function in the 'cold' tumor microenvironment of prostate cancer with a novel...
Avid Bioservices Highlights New Bioassay Capabilities to Support Phase III and Commercial-Stage Development Programs
14 mai 2013 11h00 HE | Avid Bioservices
TUSTIN, CA--(Marketwired - May 14, 2013) - Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc., today announced that its recent success in qualifying an...